<?xml version='1.0' encoding='utf-8'?>
<document id="31415873"><sentence text="Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model."><entity charOffset="29-37" id="DDI-PubMed.31415873.s1.e0" text="colistin" /><entity charOffset="42-55" id="DDI-PubMed.31415873.s1.e1" text="ciprofloxacin" /><pair ddi="false" e1="DDI-PubMed.31415873.s1.e0" e2="DDI-PubMed.31415873.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31415873.s1.e0" e2="DDI-PubMed.31415873.s1.e1" /></sentence><sentence text="Respiratory tract infections caused by multidrug-resistant Gram-negative bacteria are serious burdens to the public" /><sentence text=" Our previous findings indicated that co-loading of colistin and ciprofloxacin via liposomes improved in vitro antimicrobial activities against multidrug resistant Pseudomonas aeruginosa as compared to the monotherapies"><entity charOffset="52-60" id="DDI-PubMed.31415873.s3.e0" text="colistin" /><entity charOffset="65-78" id="DDI-PubMed.31415873.s3.e1" text="ciprofloxacin" /><pair ddi="false" e1="DDI-PubMed.31415873.s3.e0" e2="DDI-PubMed.31415873.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31415873.s3.e0" e2="DDI-PubMed.31415873.s3.e1" /></sentence><sentence text=" The current study aims to investigate the transport behavior of colistin and ciprofloxacin in liposomes using the in vitro Calu-3 cell monolayer, which is a lung epithelial model cultured under the air-interfaced condition"><entity charOffset="65-73" id="DDI-PubMed.31415873.s4.e0" text="colistin" /><entity charOffset="78-91" id="DDI-PubMed.31415873.s4.e1" text="ciprofloxacin" /><pair ddi="false" e1="DDI-PubMed.31415873.s4.e0" e2="DDI-PubMed.31415873.s4.e0" /><pair ddi="false" e1="DDI-PubMed.31415873.s4.e0" e2="DDI-PubMed.31415873.s4.e1" /></sentence><sentence text=" The cell viability results demonstrated that there was no obvious toxicity of cells exposed to single or co-administered drugs at the concentration ≤500 μg/mL" /><sentence text=" Transport of ciprofloxacin into the cells was easier than that of colistin, which reached a plateau rapidly"><entity charOffset="14-27" id="DDI-PubMed.31415873.s6.e0" text="ciprofloxacin" /><entity charOffset="67-75" id="DDI-PubMed.31415873.s6.e1" text="colistin" /><pair ddi="false" e1="DDI-PubMed.31415873.s6.e0" e2="DDI-PubMed.31415873.s6.e0" /><pair ddi="false" e1="DDI-PubMed.31415873.s6.e0" e2="DDI-PubMed.31415873.s6.e1" /></sentence><sentence text=" Colistin was less trapped in the mucus or adhered to the apical cell membrane, and less transported across the cell monolayer than ciprofloxacin"><entity charOffset="1-9" id="DDI-PubMed.31415873.s7.e0" text="Colistin" /><entity charOffset="132-145" id="DDI-PubMed.31415873.s7.e1" text="ciprofloxacin" /><pair ddi="false" e1="DDI-PubMed.31415873.s7.e0" e2="DDI-PubMed.31415873.s7.e0" /><pair ddi="false" e1="DDI-PubMed.31415873.s7.e0" e2="DDI-PubMed.31415873.s7.e1" /></sentence><sentence text=" The deposition of ciprofloxacin on the apical side increased over time (from 1 to 4 h)"><entity charOffset="19-32" id="DDI-PubMed.31415873.s8.e0" text="ciprofloxacin" /></sentence><sentence text=" There was no drug-drug interaction observed during the transport of ciprofloxacin and colistin across the cell monolayer, when they were dosed together in the solution form"><entity charOffset="69-82" id="DDI-PubMed.31415873.s9.e0" text="ciprofloxacin" /><entity charOffset="87-95" id="DDI-PubMed.31415873.s9.e1" text="colistin" /><pair ddi="false" e1="DDI-PubMed.31415873.s9.e0" e2="DDI-PubMed.31415873.s9.e0" /><pair ddi="false" e1="DDI-PubMed.31415873.s9.e0" e2="DDI-PubMed.31415873.s9.e1" /></sentence><sentence text=" The amount of drug transported across the cell monolayer was decreased in both agents when loaded in liposomes" /><sentence text=" Both drugs were more trapped in the mucus or more adhered to the apical side cell membrane of the cell monolayer when they were in liposomes" /><sentence text=" This study demonstrated that co-delivery of colistin and ciprofloxacin in a single liposome can reduce transport capacity of both drugs across the lung epithelial cell monolayer and enhance drug retention on the lung epithelial surfaces; therefore, it is a promising approach to treat the respiratory infections caused by multidrug resistant Pseudomonas aeruginosa"><entity charOffset="45-53" id="DDI-PubMed.31415873.s12.e0" text="colistin" /><entity charOffset="58-71" id="DDI-PubMed.31415873.s12.e1" text="ciprofloxacin" /><pair ddi="false" e1="DDI-PubMed.31415873.s12.e0" e2="DDI-PubMed.31415873.s12.e0" /><pair ddi="false" e1="DDI-PubMed.31415873.s12.e0" e2="DDI-PubMed.31415873.s12.e1" /></sentence><sentence text="" /></document>